Ignite Creation Date:
2025-12-24 @ 7:41 PM
Ignite Modification Date:
2026-01-13 @ 8:03 PM
Study NCT ID:
NCT03217903
Status:
UNKNOWN
Last Update Posted:
2019-08-06
First Post:
2017-07-03
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
High Risk Myelodysplasia Treated by Azacytidine : Genetic and Epigenetic (MYRAGE)
Sponsor:
Central Hospital, Nancy, France
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
MYRAGE
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |